FI280574A7 - - Google Patents

Info

Publication number
FI280574A7
FI280574A7 FI2805/74A FI280574A FI280574A7 FI 280574 A7 FI280574 A7 FI 280574A7 FI 2805/74 A FI2805/74 A FI 2805/74A FI 280574 A FI280574 A FI 280574A FI 280574 A7 FI280574 A7 FI 280574A7
Authority
FI
Finland
Application number
FI2805/74A
Other languages
Finnish (fi)
Inventor
U Kerb
R Wiechert
L Alig
A Fuerst
M Mueller
P Keller
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI280574A7 publication Critical patent/FI280574A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
FI2805/74A 1973-09-26 1974-09-26 FI280574A7 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732349024 DE2349024A1 (de) 1973-09-26 1973-09-26 6beta,7beta-epoxy-1alpha,2alphamethylen-d-homo-4-pregnen-3,20-dione

Publications (1)

Publication Number Publication Date
FI280574A7 true FI280574A7 (enExample) 1975-03-27

Family

ID=5894080

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2805/74A FI280574A7 (enExample) 1973-09-26 1974-09-26

Country Status (16)

Country Link
US (1) US3965128A (enExample)
JP (1) JPS5059362A (enExample)
AR (1) AR202946A1 (enExample)
AU (1) AU7374074A (enExample)
BE (1) BE820381A (enExample)
DD (1) DD114599A5 (enExample)
DE (1) DE2349024A1 (enExample)
DK (1) DK507974A (enExample)
FI (1) FI280574A7 (enExample)
FR (1) FR2244492A1 (enExample)
IL (1) IL45629A0 (enExample)
LU (1) LU70985A1 (enExample)
NL (1) NL7412747A (enExample)
NO (1) NO743449L (enExample)
SE (1) SE7412058L (enExample)
ZA (1) ZA746131B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999025703A1 (en) * 1997-11-14 1999-05-27 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
US6022890A (en) * 1997-11-14 2000-02-08 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
US7846915B2 (en) * 2004-10-20 2010-12-07 Resverlogix Corporation Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
WO2007016525A2 (en) * 2005-07-29 2007-02-08 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
PT2118074E (pt) 2007-02-01 2014-03-20 Resverlogix Corp Compostos para a prevenção e tratamento de doenças cardiovasculares
US8114995B2 (en) 2008-06-26 2012-02-14 Resverlogix Corp. Methods of preparing quinazolinone derivatives
ES2542835T3 (es) 2009-01-08 2015-08-12 Resverlogix Corporation Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
NZ617779A (en) 2009-03-18 2015-08-28 Resverlogix Corp Novel anti-inflammatory agents
US9757368B2 (en) 2009-04-22 2017-09-12 Resverlogix Corp. Anti-inflammatory agents
PT2773354T (pt) 2011-11-01 2019-07-17 Resverlogix Corp Formulações orais de libertação imediata para quinazolinonas substituídas
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
JP2016507496A (ja) 2012-12-21 2016-03-10 ゼニス・エピジェネティクス・コーポレイションZenith Epigenetics Corp. ブロモドメイン阻害剤としての新規複素環式化合物
CN114984016A (zh) 2015-03-13 2022-09-02 雷斯韦洛吉克斯公司 用于治疗补体相关疾病之组合物及治疗方法

Also Published As

Publication number Publication date
NO743449L (enExample) 1975-04-28
SE7412058L (enExample) 1975-03-27
BE820381A (fr) 1975-03-26
DD114599A5 (enExample) 1975-08-12
ZA746131B (en) 1975-09-24
LU70985A1 (enExample) 1975-03-06
FR2244492A1 (enExample) 1975-04-18
AR202946A1 (es) 1975-07-31
DK507974A (enExample) 1975-06-09
US3965128A (en) 1976-06-22
JPS5059362A (enExample) 1975-05-22
DE2349024A1 (de) 1975-04-10
NL7412747A (nl) 1975-04-01
AU7374074A (en) 1976-04-01
IL45629A0 (en) 1974-11-29

Similar Documents

Publication Publication Date Title
AR201758A1 (enExample)
AU476761B2 (enExample)
AU465372B2 (enExample)
AR201235Q (enExample)
AR201231Q (enExample)
AU474593B2 (enExample)
AU465453B2 (enExample)
AU465434B2 (enExample)
DK507974A (enExample)
AU450229B2 (enExample)
AU476714B2 (enExample)
AR201229Q (enExample)
AU476696B2 (enExample)
AU466283B2 (enExample)
AR199451A1 (enExample)
AU472848B2 (enExample)
AU476873B1 (enExample)
AU477823B2 (enExample)
AR200256A1 (enExample)
AR195948A1 (enExample)
AR193950A1 (enExample)
AR200885A1 (enExample)
AU471461B2 (enExample)
AU477824B2 (enExample)
AR210729A1 (enExample)